National Framework Agreement for the Supply of Immunoglobulin
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £749,380,980 |
|---|---|
| Status | complete |
| Category (CPV) | 33651520 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 28 Apr 2017 |
| Contract start | 1 Jul 2017 |
| Contract end | 30 Jun 2019 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-ec885de3-32e2-4f16-81c1-f09afc8f7a86 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Please refer to word doc called Awarded Suppliers Name | £187,345,245 | 15 Jun 2017 | active |
description
National Framework Agreement for the Supply of Immunoglobulin
Offer reference number: CM/PHS/13/5404
Period of framework agreement: 1st July 2017 to 30th June 2018 with options to extend up to a further 36 months
Additional information: National Framework Agreement for the Supply of Immunoglobulin Award Documents
documents
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d4553dcd-27c3-47fc-8516-8fcfb5535220 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/f5fe8888-5f4c-43e0-9207-14d7c626f8be , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 Jan 2015 | Planning (planning) | · | ocds-b5fd17-2f2283af-adc8-11e6-9901-0019b9f3037b-59762-cm-phs-13-5404 |
| 15 Feb 2017 | Planning (planning) | · | 7a5648ee-e04a-400c-8741-c773af5f3efa-130461 |
| 17 Aug 2018 | Award update (awardUpdate) | · | 713a33fd-f076-4db4-ae04-bbdbb254ca3d-235698 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin · NHS England · £1,200,000,000
- NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin · NHS ENGLAND
- SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT) · Ministry of Defence
- SARS-CoV-2 Nucleocapsid proteins for LFT Revalidation and Testing · UK Health Security Agency · £500,000
- CMU Framework for the supply of Anti-D Immunoglobulin · University Hospitals of Leicester NHS Trust · £209,801
- PHE_Scientific Provision for purchase of the Euroimmun Anti SARS CoV 2 IgG assay · Public Health England · £158,400
- NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga) · The NHS Commissioning Board (operating under the name of NHS England)
- 1LHE Goods - Antibodies · NEWCASTLE UNIVERSITY · £25,115
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.